We are live on ! Find out more
PASG icon

Passage Bio
PASG

48 hedge funds and large institutions have $54.4M invested in Passage Bio in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,700% more call options, than puts

Call options by funds: $48K | Put options by funds: $1K

64% more capital invested

Capital invested by funds: $33.1M → $54.4M (+$21.3M)

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

0.64% more ownership

Funds ownership: 2.99% → 3.62% (+0.64%)

4% less funds holding

Funds holding: 50 → 48 (-2)

14% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 14

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

Holders
48
Holders Change
-2
Holders Change %
-4%
% of All Funds
0.69%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
7
Increased
12
Reduced
14
Closed
9
Calls
$48K
Puts
$1K
Net Calls
+$47K
Net Calls Change
+$36K

Top Buyers

1
VPC
Vestal Point Capital
New York
+$5.41M
2
LCM
Lynx1 Capital Management
Puerto Rico
+$5.37M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$429K
4
AAA
Affinity Asset Advisors
New York
+$318K
5
FT
Fiduciary Trust
Massachusetts
+$120K

Top Sellers

1
TCM
Tang Capital Management
California
-$1.08M
2
EAM
Erste Asset Management
Austria
-$608K
3
PFCS
Pale Fire Capital SE
Czech Republic
-$529K
4
BlackRock
BlackRock
New York
-$120K
5
Citadel Advisors
Citadel Advisors
Florida
-$108K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$13.7M – – –
VVM
2
Versant Venture Management
California
$6.7M – – –
LCM
3
Lynx1 Capital Management
Puerto Rico
$6.54M +$5.37M +223,336 +1,178%
VPC
4
Vestal Point Capital
New York
$6.08M +$5.41M +225,000 New
NLVP
5
New Leaf Venture Partners
New York
$3.37M – – –
EAM
6
Erste Asset Management
Austria
$3.31M -$608K -25,250 -17%
Vanguard Group
7
Vanguard Group
Pennsylvania
$2.8M +$63.4K +2,633 +3%
TCM
8
Tang Capital Management
California
$2.02M -$1.08M -45,000 -38%
Renaissance Technologies
9
Renaissance Technologies
New York
$1.63M -$21.5K -892 -1%
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$1.3M +$429K +17,830 +59%
BlackRock
11
BlackRock
New York
$1.25M -$120K -5,001 -10%
Millennium Management
12
Millennium Management
New York
$1.17M +$93.3K +3,878 +10%
BCM
13
Bridgeway Capital Management
Texas
$751K +$59.6K +2,477 +10%
AI
14
Acuitas Investments
Washington
$634K +$62K +2,578 +12%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$519K +$62.7K +2,604 +16%
AAA
16
Affinity Asset Advisors
New York
$357K +$318K +13,213 New
Citadel Advisors
17
Citadel Advisors
Florida
$299K -$108K -4,508 -29%
FT
18
Fiduciary Trust
Massachusetts
$290K +$120K +5,000 +87%
Two Sigma Advisers
19
Two Sigma Advisers
New York
$283K -$1.08K -45 -0.4%
Two Sigma Investments
20
Two Sigma Investments
New York
$272K – – –
RC
21
RBF Capital
California
$193K – – –
PFCS
22
Pale Fire Capital SE
Czech Republic
$191K -$529K -21,991 -76%
State Street
23
State Street
Massachusetts
$167K – – –
MAM
24
Marquette Asset Management
Minnesota
$115K – – –
Northern Trust
25
Northern Trust
Illinois
$114K +$8.88K +369 +10%
1
2 3

PASG Hedge Fund Activity: Q1 2024 in Review

48 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Passage Bio (PASG) for Q1 2024, worth a combined $54.4M — up 64% from $33.1M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of PASG and 7 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 12 added.

The largest buyer was Vestal Point Capital, opening a new position worth an estimated $5.41M. The largest seller was Tang Capital Management, cutting an estimated $1.08M.

  • 48 institutional investors held Passage Bio (PASG) as of Q1 2024, down from 50 in Q4 2023.
  • Funds reported $54.4M of Passage Bio stock for Q1 2024, up 64% quarter-over-quarter.
  • 7 funds opened new Passage Bio positions in Q1 2024 and 9 closed out, a net change of -2 holders.
  • The largest Passage Bio buyer in Q1 2024 was Vestal Point Capital, an estimated $5.41M added.
  • The largest Passage Bio seller in Q1 2024 was Tang Capital Management, an estimated $1.08M sold.

Based on aggregated 13F filings for Q1 2024.